Nanospectra Biosciences Revenue and Competitors

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Nanospectra Biosciences's estimated annual revenue is currently $3.5M per year.(i)
  • Nanospectra Biosciences's estimated revenue per employee is $1,750,000

Employee Data

  • Nanospectra Biosciences has 2 Employees.(i)
  • Nanospectra Biosciences grew their employee count by 0% last year.

Nanospectra Biosciences's People

NameTitleEmail/Phone
1
COO & VP, Process Development & ChemistryReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Dir ClinicalResearchReveal Email/Phone
5
Operations AdministratorReveal Email/Phone
6
Member Board Directors, Strategic ConsultantReveal Email/Phone
7
Senior Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A38533%N/AN/A
#2
N/A11-31%N/AN/A
#3
$1.7M620%N/AN/A
#4
$15M21316%N/AN/A
#5
$3.5M14-30%N/AN/A
#6
$15M171-3%N/AN/A
#7
N/A24100%N/AN/A
#8
N/A190%N/AN/A
#9
N/A4837%N/AN/A
#10
N/A11456%N/AN/A
Add Company

What Is Nanospectra Biosciences?

Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation. AuroLase, the company's lead product for the ablation of prostate cancer tissue, is the first and only ultra-focal tissue ablation therapy designed to maximize treatment efficacy while minimizing side effects typically associated with surgery, radiation, and traditional focal therapies. Implementing a multi-prong growth strategy, Nanospectra is focusing on clinical advancements, exclusive partnering agreements and ongoing research and development. Nanospectra’s technology development has been funded to date by a series of grants, private equity investments and corporate partnerships.

keywords:N/A

N/A

Total Funding

2

Number of Employees

$3.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M2-96%N/A
#2
$0.2M2-71%N/A
#3
$0.3M2-87%N/A
#4
$0.1M20%N/A
#5
$0.2M20%N/A